99 related articles for article (PubMed ID: 19573895)
1. Hyperglycaemia impairs antithrombin secretion: possible contribution to the thrombotic risk of diabetes.
Hernández-Espinosa D; Ordóñez A; Miñano A; Martínez-Martínez I; Vicente V; Corral J
Thromb Res; 2009 Sep; 124(4):483-9. PubMed ID: 19573895
[TBL] [Abstract][Full Text] [Related]
2. Effects of acrolein, a natural occurring aldehyde, on the anticoagulant serpin antithrombin.
Martínez-Martínez I; Ordóñez A; Guerrero JA; Pedersen S; Miñano A; Teruel R; Velázquez L; Kristensen SR; Vicente V; Corral J
FEBS Lett; 2009 Oct; 583(19):3165-70. PubMed ID: 19729010
[TBL] [Abstract][Full Text] [Related]
3. Latent and polymeric antithrombin: clearance and potential thrombotic risk.
Corral J; Rivera J; Guerrero JA; Miñano A; Alberca I; Hernández-Espinosa D; Ordóñez A; Martínez C; Navarro-Núñez L; González-Conejero R; Lozano ML; Vicente V
Exp Biol Med (Maywood); 2007 Feb; 232(2):219-26. PubMed ID: 17259329
[TBL] [Abstract][Full Text] [Related]
4. L-asparaginase-induced antithrombin type I deficiency: implications for conformational diseases.
Hernández-Espinosa D; Miñano A; Martínez C; Pérez-Ceballos E; Heras I; Fuster JL; Vicente V; Corral J
Am J Pathol; 2006 Jul; 169(1):142-53. PubMed ID: 16816368
[TBL] [Abstract][Full Text] [Related]
5. Intracellular retention of hepatic serpins caused by severe hyperlipidemia.
Hernández-Espinosa D; Ayala I; Castells MT; García-Pérez B; Martín-Castillo A; Miñano A; Arcas I; Vicente V; Corral J
Liver Int; 2006 Aug; 26(6):708-15. PubMed ID: 16842328
[TBL] [Abstract][Full Text] [Related]
6. Hyperglycemia accelerates arterial thrombus formation and attenuates the antithrombotic response to endotoxin in mice.
Hansen HR; Wolfs JL; Bruggemann L; Sommeijer DW; Bevers E; Hauer AD; Kuiper J; Spek CA; Spronk HM; Reitsma PH; ten Cate H
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):627-36. PubMed ID: 17890950
[TBL] [Abstract][Full Text] [Related]
7. Beta-cell function and mass in type 2 diabetes.
Larsen MO
Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of proteasome by bortezomib causes intracellular aggregation of hepatic serpins and increases the latent circulating form of antithrombin.
Hernández-Espinosa D; Miñano A; Martínez C; Ordoñez A; Pérez-Ceballos E; de Arriba F; Mota RA; Ferrer F; González M; Vicente V; Corral J
Lab Invest; 2008 Mar; 88(3):306-17. PubMed ID: 18195690
[TBL] [Abstract][Full Text] [Related]
9. Detection of conformational transformation of antithrombin in blood with crossed immunoelectrophoresis: new application for a classical method.
Corral J; Rivera J; Martínez C; González-Conejero R; Miñano A; Vicente V
J Lab Clin Med; 2003 Nov; 142(5):298-305. PubMed ID: 14647033
[TBL] [Abstract][Full Text] [Related]
10. Factors with conformational effects on haemostatic serpins: implications in thrombosis.
Hernández-Espinosa D; Ordóñez A; Vicente V; Corral J
Thromb Haemost; 2007 Sep; 98(3):557-63. PubMed ID: 17849043
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal studies of time-dependent changes in both bladder and erectile function after streptozotocin-induced diabetes in Fischer 344 male rats.
Melman A; Zotova E; Kim M; Arezzo J; Davies K; DiSanto M; Tar M
BJU Int; 2009 Nov; 104(9):1292-300. PubMed ID: 19389003
[TBL] [Abstract][Full Text] [Related]
12. In vivo effects of hyperthermia on the functional and conformational characteristics of antithrombin.
Hernández-Espinosa D; Mota R; Miñano A; Ordóñez A; Yélamos J; Vicente V; Corral J
J Thromb Haemost; 2007 May; 5(5):963-70. PubMed ID: 17472584
[TBL] [Abstract][Full Text] [Related]
13. Thrombosis as a conformational disease.
Corral J; Vicente V; Carrell RW
Haematologica; 2005 Feb; 90(2):238-46. PubMed ID: 15710578
[TBL] [Abstract][Full Text] [Related]
14. The effects of hyperglycaemia on thrombin-activatable fibrinolysis inhibitor.
Verkleij CJ; Nieuwdorp M; Gerdes VE; Mörgelin M; Meijers JC; Marx PF
Thromb Haemost; 2009 Sep; 102(3):460-8. PubMed ID: 19718465
[TBL] [Abstract][Full Text] [Related]
15. Life-threatening thrombosis in mice with targeted Arg48-to-Cys mutation of the heparin-binding domain of antithrombin.
Dewerchin M; Hérault JP; Wallays G; Petitou M; Schaeffer P; Millet L; Weitz JI; Moons L; Collen D; Carmeliet P; Herbert JM
Circ Res; 2003 Nov; 93(11):1120-6. PubMed ID: 14592998
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of human pancreatic proteinases by human plasma alpha2-antiplasmin and antithrombin.
Nobar SM; Guy-Crotte O; Rabaud M; Bieth JG
Biol Chem; 2004 May; 385(5):423-7. PubMed ID: 15196003
[TBL] [Abstract][Full Text] [Related]
17. Protein Z/Z-dependent protease inhibitor (PZ/ZPI) anticoagulant system and thrombosis.
Corral J; González-Conejero R; Hernández-Espinosa D; Vicente V
Br J Haematol; 2007 Apr; 137(2):99-108. PubMed ID: 17391489
[TBL] [Abstract][Full Text] [Related]
18. The conformational basis of thrombosis.
Carrell RW; Huntington JA; Mushunje A; Zhou A
Thromb Haemost; 2001 Jul; 86(1):14-22. PubMed ID: 11487000
[TBL] [Abstract][Full Text] [Related]
19. Antithrombin activity is inhibited by acrolein and homocysteine thiolactone: Protection by cysteine.
Gugliucci A
Life Sci; 2008 Feb; 82(7-8):413-8. PubMed ID: 18206177
[TBL] [Abstract][Full Text] [Related]
20. Endovenous administration of bone-marrow-derived multipotent mesenchymal stromal cells prevents renal failure in diabetic mice.
Ezquer F; Ezquer M; Simon V; Pardo F; Yañez A; Carpio D; Conget P
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1354-65. PubMed ID: 19822294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
